Decreasing Quality of the New Generations of Anti-Müllerian Hormone Assays

Abstract EN

Anti-Müllerian hormone (AMH) measurements are widely used to optimize the stimulation protocols.

First generation AMH kits correlated well with ovarian reserve and response to stimulation.

In the present study we aimed to asses if the new generation kits share the same accurate correlations.

Retrospective data were collected from 8323 blood samples.

For comparison we used Immunotech I generation kit (ImI 4035 samples), Beckman Coulter II generation kit RUO (BCII RUO 3449, samples) and Beckman Coulter II generation kit with IVD certificate (BCII IVD 839 samples).

We compared average AMH concentrations measured with different kits, as well as correlation between kits.

We also compared average AMH concentrations in sera collected on different cycle days and samples of different quality of preservation.

AMH serum concentrations differed for each kit, ranging 4.4 ± 4.12 (mean ± SD) for the ImI, 2.68 ± 3.15 for the BCII RUO, and 1.64 ± 2.85 for BCII IVD.

The mean differences from an adjusted regression model were −48.7%, −40%, and −69.2%, respectively.

In conclusion, the changes of the BC AMH kits are unpredictable; however, the improvement of them is still possible.

It would be very dangerous to use elaborated stimulation protocol (based on the Ist generation AMH results) with the results from the IInd generation assays.